Clinical trial
Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers…
NCT00170768 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00170768 |
|---|---|
| Title | Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over |
| Official title | Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Drug |
| Interventions | Darifenacin, Oxybutynin, Placebo |
| Enrollment | 150 |
| Start date | Feb 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 23, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: